unknown
Stage
About
Allero Therapeutics is a biotechnology company developing non-invasive, antigen-specific immunotherapies to induce long-lasting immune tolerance for autoimmune and allergic diseases and to prevent anti-drug antibodies. Its proprietary SOMIT (Specific OroMucosal ImmunoTherapy) platform is being applied to programs including celiac disease and food allergy.
Explore Allero Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.